✦ LIBER ✦

Effect of Glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab

✍ Scribed by S. Rossi; C. Motta; V. Studer; V. De Chiara; F. Barbieri; F. Monteleone; A. Fornasiero; G. Coarelli; G. Bernardi; G. Cutter; O. Stüve; M. Salvetti; D. Centonze

Book ID: 115236471
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 656 KB
Volume: 20
Category: Article
ISSN: 1351-5101
DOI: 10.1111/j.1468-1331.2012.03794.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Glatiramer acetate on disease

Effect of Glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab

✍ S. Rossi; C. Motta; V. Studer; V. De Chiara; F. Barbieri; F. Monteleone; A. Forn 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

## Background and purpose Multiple sclerosis (MS) patients discontinuing natalizumab are at risk of rebound of disease activity. ## Methods In the present multi‐center, open‐label, non‐randomized, prospective, pilot study, we tested whether treatment with glatiramer acetate (GA) is safe and effec

Glatiramer acetate has a favourable effe

Glatiramer acetate has a favourable effect on tissue disruption in pre-existing MS lesions

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Cost-Effectiveness Analyses of Natalizum

Cost-Effectiveness Analyses of Natalizumab for 2nd Line Versus Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients in Brazil

✍ Nishikawa, A.M.; Paladini, L.; Liamas, A.L.; Bueno, C.C.; Clark, O.A.C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Comparison of subcutaneous interferon be

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

✍ Daniel D Mikol; Frederik Barkhof; Peter Chang; Patricia K Coyle; Douglas R Jeffe 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 216 KB

PND13 A COST-EFFECTIVENESS ANALYSIS OF N

PND13 A COST-EFFECTIVENESS ANALYSIS OF NATALIZUMAB VS. INTERFERON-BETA AND GLATIRAMER ACETATE IN PATIENTS WITH ACTIVE RELAPSING-REMITTING MULTIPLE SCLEROSIS CURRENTLY FAILING ON EXISTING THERAPY

✍ R Gani; ER Samuels; S Hughes; G Giovanonni 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Effects of oral glatiramer acetate on cl

Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study

✍ Massimo Filippi; Jerry S Wolinsky; Giancarlo Comi 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 185 KB